Skip to content

The effect of nutrition bio-shield superfood in the treatment of human papilloma virus

The effective dose of nutrition bio-shield (NBS) superfood in the treatment of women with human papilloma virus (HPV)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
IRCT
Registry ID
IRCT20250220064778N1
Enrollment
48
Registered
2025-05-13
Start date
2025-04-09
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

????? ????????? ??????. Anogenital (venereal) warts

Interventions

Intervention 1: The first intervention group: which includes 12 patients and will receive 2.5 grams of NBS (a herbal blend containing nutritious cereal grains and other herbal materials
manufactured by NBS organic company in Istanbul, Turkey) once a day. Intervention 2: The second intervention group: which includes 12 patients and will receive 5 grams of NBS once a day. Intervention

Sponsors

Hamedan University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: Women with genital lesions who have been confirmed to have HPV by Pap smear

Exclusion criteria

Exclusion criteria: Patients taking specific medication regularly or with specific diseases

Design outcomes

Primary

MeasureTime frame
HPV lesion healing. Timepoint: 3 and 6 months after taking NBS. Method of measurement: Clinically, by examining the lesions, which will be recorded at the beginning and at the 3rd and 6th month visits. Also, molecularly, by performing a Pap smear at the beginning and at the 3rd and 6th month, the degree of improvement will be determined.

Secondary

MeasureTime frame
Impact of NBS on immune status by measuring INF- ?, IgG1. Timepoint: At the beginning of the study and at months 3 and 6. Method of measurement: serum sample.;The effect of NBS on other organs by measuring cell blood counts, liver and kidney enzymes, lipid profiles, and fasting blood sugar. Timepoint: At the beginning of the study and at months 3 and 6. Method of measurement: serum sample.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFarid Azizi Jalilian

Hamedan University of Medical Sciences

azizifarid@gmail.com+98 81 3525 0182

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026